healthy people
Conditions
Interventions
meal1:Airfryer cooked meal
meal2:Deepfryer cooked meal
meal3:High fat meal
Sponsors
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Male or female subjects, aged 18-35 years, in apparently good general health condition; 2. BMI 18.5 to 24.0, body height 150cm to 180cm, waist circumference < 90 cm (for male) or < 85 cm (for female); 3. Subjects have eaten fried food; 4. Subjects having given written consent to take part in the study and willing to complete all study visits;Inclusion criteria: 1. Male or female subjects, aged 18-35 years, in apparently good general health condition; 2. BMI 18.5 to 24.0, body height 150cm to 180cm, waist circumference < 90 cm (for male) or < 85 cm (for female); 3. Subjects have eaten fried food; 4. Subjects having given written consent to take part in the study and willing to complete all study visits;Inclusion criteria: 1. Male or female subjects, aged 18-35 years, in apparently good general health condition; 2. BMI 18.5 to 24.0, body height 150cm to 180cm, waist circumference < 90 cm (for male) or < 85 cm (for female); 3. Subjects have eaten fried food; 4. Subjects having given written consent to take part in the study and willing to complete all study visits;Inclusion criteria: 1. Male or female subjects, aged 18-35 years, in apparently good general health condition; 2. BMI 18.5 to 24.0, body height 150cm to 180cm, waist circumference < 90 cm (for male) or < 85 cm (for female); 3. Subjects have eaten fried food; 4. Subjects having given written consent to take part in the study and willing to complete all study visits;Inclusion criteria: 1. Male or female subjects, aged 18-35 years, in apparently good general health condition; 2. BMI 18.5 to 24.0, body height 150cm to 180cm, waist circumference < 90 cm (for male) or < 85 cm (for female); 3. Subjects have eaten fried food; 4. Subjects having given written consent to take part in the study and willing to complete all study visits
Exclusion criteria
Exclusion criteria: 1. Have any health conditions or factors that the Principal Investigator (PI) believes may affect the response of the body or the interpretation of the test results, including any clinically diagnosed diabetes, pre-diabetes, dyslipidemia, cardiovascular or gastrointestinal diseases, metabolic syndrome, gallbladder diseases, kidney and liver diseases, hyperthyroidism or hypothyroidism, abnormal clinical condition related with abnormal lipid metabolism and blood glucose response; ? Be currently taking or having taken any medication affecting blood glucose, lipid metabolism, and digestion system such as insulin, antihypertensives, laxatives, potassium chloride, or vitamin or enzyme supplements which the PI or designee believes may influence the blood glucose, lipid metabolism, food digestion and absorption or the interpretation of the data; 2. Subjects who have undergone any surgery on cardiovascular and gastrointestinal system (e.g., pancreas, liver, gallbladder, stomach and intestine); 3. Have high diabetes risk, e.g. have first-degree relatives diagnosed with diabetes, woman had gestational diabetes; 4. Have anemia (hemoglobin 5 cigarettes/day); 11. Have vigorous activity (e.g., >5 times per week, running for more than 30 minutes every time); 12. Subjects who are allergic to the food provided; 13. Subjects who have not eaten fried food before; 14. Subjects who have acupuncture syncope or hematophobia; 15. Concurrent participation in any other clinical study; 16. Subjects in a situation which in the view of the investigator could interfere with optimal participation in the study or constitute a special risk for these subjects (e.g vegetarians).;Exclusion criteria: 1. Have any health conditions or factors that the Principal Investigator (PI) believes may affect the response of the body or the interpretation of the test results, including any clinically diagnosed diabetes, pre-diabetes, dyslipidemia, cardiovascular or gastrointestinal diseases, metabolic syndrome, gallbladder diseases, kidney and liver diseases, hyperthyroidism or hypothyroidism, abnormal clinical condition related with abnormal lipid metabolism and blood glucose response; ? Be currently taking or having taken any medication affecting blood glucose, lipid metabolism, and digestion system such as insulin, antihypertensives, laxatives, potassium chloride, or vitamin or enzyme supplements which the PI or designee believes may influence the blood glucose, lipid metabolism, food digestion and absorption or the interpretation of the data; 2. Subjects who have undergone any surgery on cardiovascular and gastrointestinal system (e.g., pancreas, liver, gallbladder, stomach and intestine); 3. Have high diabetes risk, e.g. have first-degree relatives diagnosed with diabetes, woman had gestational diabetes; 4. Have anemia (hemoglobin 5 cigarettes/day); 11. Have vigorous activity (e.g., >5 times per week, running for more than 30 minutes every time); 12. Subjects who are allergic to the food provided; 13. Subjects who have not eaten fried food before; 14. Subjects who have acupuncture syncope or hematophobia; 15. Concurrent participation in any other clinical study; 16. Subjects in a situation which in the view of the investigator could interfere with optimal participation in the study or constitute a special risk for these subjects (e.g vegetarians).;Exclusion criteria: 1. Have any health conditions or factors that the Principal Investigator (PI) believes may affect the response of the body or the interpretation of the test results, including any clinically diagnosed diabetes, pre-diabetes, dyslipidemia, cardiovascular or gastrointestinal diseases, metabolic syndrome, gallbladder diseases, kidney and liver diseases, hyperthyroidism or hypothyroidism, abnormal clinical condition related with abnormal lipid metabolism and blood glucose response; ? Be currently taking or having taken any medication affecting blood glucose, lipid metabolism, and digestion system such as insulin, antihypertensives, laxatives, potassium chloride, or vitamin or enzyme supplements which the PI or designee believes may influence the blood glucose, lipid metabolism, food digestion and absorption or the interpretation of the data; 2. Subjects who have undergone any surgery on cardiovascular and gastrointestinal system (e.g., pancreas, liver, gallbladder, stomach and intestine); 3. Have high diabetes risk, e.g. have first-degree relatives diagnosed with diabetes, woman had gestational diabetes; 4. Have anemia (hemoglobin 5 cigarettes/day); 11. Have vigorous activity (e.g., >5 times per week, running for more than 30 minutes every time); 12. Subjects who are allergic to the food provided; 13. Subjects who have not eaten fried food before; 14. Subjects who have acupuncture syncope or hematophobia; 15. Concurrent participation in any other clinical study; 16. Subjects in a situation which in the view of the investigator could interfere with optimal participation in the study or constitute a special risk for these subjects (e.g vegetarians).;Exclusion criteria: 1. Have any health conditions or factors that the Principal Investigator (PI) believes may affect the response of the body or the interpretation of the test results, including any clinically diagnosed diabetes, pre-diabetes, dyslipidemia, cardiovascular or gastrointestinal diseases, metabolic syndrome, gallbladder diseases, kidney and liver diseases, hyperthyroidism or hypothyroidism, abnormal clinical condition related with abnormal lipid metabolism and blood glucose response; ? Be currently taking or having taken any medication affecting blood glucose, lipid metabolism, and digestion system such as insulin, antihypertensives, laxatives, potassium chloride, or vitamin or enzyme supplements which the PI or designee believes may influence the blood glucose, lipid metabolism, food digestion and absorption or the interpretation of the data; 2. Subjects who have undergone any surgery on cardiovascular and gastrointestinal system (e.g., pancreas, liver, gallbladder, stomach and intestine); 3. Have high diabetes risk, e.g. have first-degree relatives diagnosed with diabetes, woman had gestational diabetes; 4. Have anemia (hemoglobin 5 cigarettes/day); 11. Have vigorous activity (e.g., >5 times per week, running for more than 30 minutes every time); 12. Subjects who are allergic to the food provided; 13. Subjects who have not eaten fried food before; 14. Subjects who have acupuncture syncope or hematophobia; 15. Concurrent participation in any other clinical study; 16. Subjects in a situation which in the view of the investigator could interfere with optimal participation in the study or constitute a special risk for these subjects (e.g vegetarians).;Exclusion criteria: 1. Have any health conditions or factors that the Principal Investigator (PI) believes may affect the response of the body or the interpretation of the test results, including any clinically diagnosed diabetes, pre-diabetes, dyslipidemia, cardiovascular or gastrointestinal diseases, metabolic syndrome, gallbladder diseases, kidney and liver diseases, hyperthyroidism or hypothyroidism, abnormal clinical condition related with abnormal lipid metabolism and blood glucose response; ? Be currently taking or having taken any medication affecting blood glucose, lipid metabolism, and digestion system such as insulin, antihypertensives, laxatives, potassium chloride, or vitamin or enzyme supplements which the PI or designee believes may influence the blood glucose, lipid metabolism, food digestion and absorption or the interpretation of the data; 2. Subjects who have undergone any surgery on cardiovascular and gastrointestinal system (e.g., pancreas, liver, gallbladder, stomach and intestine); 3. Have high diabetes risk, e.g. have first-degree relatives diagnosed with diabetes, woman had gestational diabetes; 4. Have anemia (hemoglobin 5 cigarettes/day); 11. Have vigorous activity (e.g., >5 times per week, running for more than 30 minutes every time); 12. Subjects who are allergic to the food provided; 13. Subjects who have not eaten fried food before; 14. Subjects who have acupuncture syncope or hematophobia; 15. Concurrent participation in any other clinical study; 16. Subjects in a situation which in the view of the investigator could interfere with optimal participation in the study or constitute a special risk for these subjects (e.g vegetarians).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TG; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Glucose;HDL-C;LDL-C;TC;FFA;insulin; | — |
Countries
China
Contacts
Public ContactSheng Ge;Sheng Ge;Sheng Ge;Sheng Ge;Sheng Ge ;;;;
Shanghai Jiao Tong University Affiliated Sixth People's Hospital;Shanghai Jiao Tong University Affiliated Sixth People's Hospital;Shanghai Jiao Tong University Affiliated Sixth People's Hospital;Shanghai Jiao Tong University Affiliated Sixth People's Hospital;Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Outcome results
None listed